Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China

Background Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule. Several mumps outbreaks have occurred recently in Fujian. Serological surveillance can assess pop...

Descripció completa

Dades bibliogràfiques
Autors principals: Dong Li, Hairong Zhang, Na You, Zhifei Chen, Xiuhui Yang, Hangsu Zhang, Yong Zhou, Ningxuan Zheng, Weiyi Pan
Format: Article
Idioma:English
Publicat: Taylor & Francis Group 2022-11-01
Col·lecció:Human Vaccines & Immunotherapeutics
Matèries:
Accés en línia:http://dx.doi.org/10.1080/21645515.2022.2096375
_version_ 1827806402052096000
author Dong Li
Hairong Zhang
Na You
Zhifei Chen
Xiuhui Yang
Hangsu Zhang
Yong Zhou
Ningxuan Zheng
Weiyi Pan
author_facet Dong Li
Hairong Zhang
Na You
Zhifei Chen
Xiuhui Yang
Hangsu Zhang
Yong Zhou
Ningxuan Zheng
Weiyi Pan
author_sort Dong Li
collection DOAJ
description Background Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule. Several mumps outbreaks have occurred recently in Fujian. Serological surveillance can assess population immunity to mumps and identify risk factors for mumps. Methods We conducted a cross-sectional serosurvey of mumps IgG antibodies in the general population of Fujian Province in 2018 and compare results with a similar study conducted in 2009, when the routine schedule had no MuCV. We analyzed changes in mumps epidemiology after implementation of a one-dose MuCV vaccination strategy. Results Mumps seroprevalence was 78.6% (95% CI: 77.4–79.8), and the geometric mean concentration (GMC) of mumps antibodies was 245.8 IU/ml (95% CI:237.3–255.1). MuCV vaccination at 18 months resulted in increased seroprevalence and GMCs. Seroprevalence and GMCs varied by age, gender, and number of doses received. Except for children under 18 months, seroprevalence and GMCs were lowest among 10-15-year-olds. Each year after introduction of the one-dose MuCV vaccination policy, the highest incidence of mumps was among 4–6-year-olds and 9–15-year-olds, gradually shifting to older age groups. Conclusion A one-dose mumps-containing vaccine schedule does not provide sustained and stable mumps immunity in Fujian. To reduce the risk of mumps, we recommend supplementary vaccination of children without a history of receiving at least one MuCV dose or who are seronegative at 10–15 years of age.
first_indexed 2024-03-11T21:40:39Z
format Article
id doaj.art-60d94b51a2f44d08abd9f7b690694d67
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T21:40:39Z
publishDate 2022-11-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-60d94b51a2f44d08abd9f7b690694d672023-09-26T13:19:08ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-11-0118610.1080/21645515.2022.20963752096375Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, ChinaDong Li0Hairong Zhang1Na You2Zhifei Chen3Xiuhui Yang4Hangsu Zhang5Yong Zhou6Ningxuan Zheng7Weiyi Pan8Fujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionBackground Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule. Several mumps outbreaks have occurred recently in Fujian. Serological surveillance can assess population immunity to mumps and identify risk factors for mumps. Methods We conducted a cross-sectional serosurvey of mumps IgG antibodies in the general population of Fujian Province in 2018 and compare results with a similar study conducted in 2009, when the routine schedule had no MuCV. We analyzed changes in mumps epidemiology after implementation of a one-dose MuCV vaccination strategy. Results Mumps seroprevalence was 78.6% (95% CI: 77.4–79.8), and the geometric mean concentration (GMC) of mumps antibodies was 245.8 IU/ml (95% CI:237.3–255.1). MuCV vaccination at 18 months resulted in increased seroprevalence and GMCs. Seroprevalence and GMCs varied by age, gender, and number of doses received. Except for children under 18 months, seroprevalence and GMCs were lowest among 10-15-year-olds. Each year after introduction of the one-dose MuCV vaccination policy, the highest incidence of mumps was among 4–6-year-olds and 9–15-year-olds, gradually shifting to older age groups. Conclusion A one-dose mumps-containing vaccine schedule does not provide sustained and stable mumps immunity in Fujian. To reduce the risk of mumps, we recommend supplementary vaccination of children without a history of receiving at least one MuCV dose or who are seronegative at 10–15 years of age.http://dx.doi.org/10.1080/21645515.2022.2096375mumpsseroprevalencevaccinationmeasles-mumps-rubella vaccine (mmr)geometric mean concentration (gmc)
spellingShingle Dong Li
Hairong Zhang
Na You
Zhifei Chen
Xiuhui Yang
Hangsu Zhang
Yong Zhou
Ningxuan Zheng
Weiyi Pan
Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
Human Vaccines & Immunotherapeutics
mumps
seroprevalence
vaccination
measles-mumps-rubella vaccine (mmr)
geometric mean concentration (gmc)
title Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
title_full Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
title_fullStr Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
title_full_unstemmed Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
title_short Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
title_sort mumps serological surveillance following 10 years of a one dose mumps containing vaccine policy in fujian province china
topic mumps
seroprevalence
vaccination
measles-mumps-rubella vaccine (mmr)
geometric mean concentration (gmc)
url http://dx.doi.org/10.1080/21645515.2022.2096375
work_keys_str_mv AT dongli mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina
AT hairongzhang mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina
AT nayou mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina
AT zhifeichen mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina
AT xiuhuiyang mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina
AT hangsuzhang mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina
AT yongzhou mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina
AT ningxuanzheng mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina
AT weiyipan mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina